Novel Single-Chain Antibody GD3A10 Defines a Chondroitin Sulfate Biomarker for Ovarian Cancer

References

• Ovarian cancer, five-year stage-specific relative survival rates (2004–2008). J. Natl Cancer Inst. 103 (17), 1287 (2011).
   PubMedGoogle Scholar
• Jemal A , SiegelR, XuJ, WardE. Cancer statistics, 2010.CA Cancer J. Clin.60 (5), 277 – 300 (2010).
   PubMed Web of Science ®Google Scholar
• Bissell MJ , RadiskyDC, RizkiA, WeaverVM, PetersenOW. The organizing principle: microenvironmental influences in the normal and malignant breast.Differentiation70 (9–10), 537 – 546 (2002).
   PubMed Web of Science ®Google Scholar
• Kenny PA , BissellMJ. Tumor reversion: correction of malignant behavior by microenvironmental cues.Int. J. Cancer107 (5), 688 – 695 (2003).
   PubMed Web of Science ®Google Scholar
• Pupa SM , MenardS, FortiS, TagliabueE. New insights into the role of extracellular matrix during tumor onset and progression.J. Cell. Physiol.192 (3), 259 – 267 (2002).
   PubMed Web of Science ®Google Scholar
• Bissell MJ , KennyPA, RadiskyDC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.Cold Spring Harb. Symp. Quant. Biol.70, 343 – 356 (2005).
   PubMedGoogle Scholar
• Ghosh S , AlbitarL, LebaronRet al. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol. Oncol. 119 (1), 114 – 120 (2010).
   PubMed Web of Science ®Google Scholar
• Tlsty TD , CoussensLM. Tumor stroma and regulation of cancer development.Ann. Rev. Pathol.1, 119 – 150 (2006).
   PubMed Web of Science ®Google Scholar
• Wegrowski Y , MaquartFX. Involvement of stromal proteoglycans in tumour progression.Crit. Rev. Oncol. Hematol.49 (3), 259 – 268 (2004).
   PubMed Web of Science ®Google Scholar
• Labiche A , HeutteN, HerlinP, ChasleJ, GauduchonP, ElieN. Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma.Int. J. Gynecol. Cancer20 (1), 28 – 33 (2010).
   PubMed Web of Science ®Google Scholar
• Wolanska M , SobolewskiK, BankowskiE, DrozdzewiczM. Accumulation of collagen in ovarian benign tumours.Acta Biochim. Pol.46 (4), 941 – 947 (1999).
   PubMed Web of Science ®Google Scholar
• Ten Dam GB , YamadaS, KobayashiFet al. Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas Histochem. Cell Biol. 132 (1), 117 – 127 (2009).
   PubMed Web of Science ®Google Scholar
• Bellin ME , AxRL. Chemical characteristics of follicular glycosaminoglycans.Adv. Exp. Med. Biol.219, 731 – 735 (1987).
   PubMedGoogle Scholar
• Hatzirodos N , NigroJ, Irving-RodgersHFet al. Glycomic analyses of ovarian follicles during development and atresia. Matrix Biol. 31 (1), 45 – 56 (2012).
   PubMed Web of Science ®Google Scholar
• Voutilainen K , AnttilaM, SillanpaaSet al. Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int. J. Cancer 107 (3), 359 – 364 (2003).
   PubMed Web of Science ®Google Scholar
• Ten Dam GB , Van De WesterloEM, PurushothamanAet al. Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am. J. Pathol. 171 (4), 1324 – 1333 (2007).
   PubMed Web of Science ®Google Scholar
• Nakano T , FujiiJ, TamuraSet al. Glycosaminoglycan in malignant pleural mesothelioma. Cancer 57 (1), 106 – 110 (1986).
   PubMed Web of Science ®Google Scholar
• Theocharis AD , VyniosDH, PapageorgakopoulouN, SkandalisSS, TheocharisDA. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma.Int. J. Biochem. Cell Biol.35 (3), 376 – 390 (2003).
   PubMed Web of Science ®Google Scholar
• Adany R , HeimerR, CatersonB, SorrellJM, IozzoRV. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels.J. Biol. Chem.265 (19), 11389 – 11396 (1990).
   PubMed Web of Science ®Google Scholar
• Skandalis SS , StylianouM, VyniosDH, PapageorgakopoulouN, TheocharisDA. The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer.Biochimie89 (12), 1573 – 1580 (2007).
   PubMed Web of Science ®Google Scholar
• Afratis N , GialeliC, NikitovicDet al. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 279 (7), 1177 – 1197 (2012).
   PubMed Web of Science ®Google Scholar
• Pothacharoen P , SiriaunkgulS, Ong-ChaiSet al. Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer. J. Biochem. 140 (4), 517 – 524 (2006).
   PubMed Web of Science ®Google Scholar
• Vallen MJ , MassugerLF, Ten DamGB, BultenJ, Van KuppeveltTH. Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue.Gynecol. Oncol.127 (1), 202 – 209 (2012).
   PubMed Web of Science ®Google Scholar
• Cattaruzza S , NicolosiPA, PerrisR. Proteoglycans in the control of tumor growth and metastasis formation.Connect. Tissue Res.49 (3), 225 – 229 (2008).
   PubMed Web of Science ®Google Scholar
• Iozzoa RV , SandersonbRD. Proteoglycans in cancer biology, tumor microenvironment and angiogenesis.J. Cell Mol. Med.15 (5), 1013 – 1031 (2010).
   Web of Science ®Google Scholar
• Seidman JD , RussellP, KurmanRJ. Surface epithelial tumor of the ovary. In: Blaustein’s Pathology of the Femal Genetal Tract.KurmanRJ (Ed.). Springer, NY, USA, 791 – 904 (2002).
   Google Scholar
• Heintz AP , OdicinoF, MaisonneuvePet al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95 (Suppl. 1), S161 – S192 (2006).
   PubMed Web of Science ®Google Scholar
• Ten Dam GB , KurupS, Van De WesterloEMet al. 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 281 (8), 4654 – 4662 (2006).
   PubMed Web of Science ®Google Scholar
• Lensen JF , WijnhovenTJ, KuikLHet al. Selection and characterization of a unique phage display-derived antibody against dermatan sulfate. Matrix Biol. 25 (7), 457 – 461 (2006).
   PubMed Web of Science ®Google Scholar
• Nissim A , HoogenboomHR, TomlinsonIMet al. Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents. EMBO J. 13 (3), 692 – 698 (1994).
   PubMed Web of Science ®Google Scholar
• Takada W , FukushimaM, PothacharoenP, KongtawelertP, SugaharaK. A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies.Anal. Biochem.435 (2), 123 – 130 (2013).
   PubMed Web of Science ®Google Scholar
• Smetsers TF , Van De WesterloEM, Ten DamGBet al. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J. Invest. Dermatol. 122 (3), 707 – 716 (2004).
   PubMed Web of Science ®Google Scholar
• Hagemeyer CE , Von Zur MuhlenC, Von ElverfeldtD, PeterK. Single-chain antibodies as diagnostic tools and therapeutic agents.Thromb. Haemost.101 (6), 1012 – 1019 (2009).
   PubMed Web of Science ®Google Scholar
• Peng XH , WangY, HuangDet al. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano 5 (12), 9480 – 9493 (2011).
   PubMed Web of Science ®Google Scholar
• Kusumoto T , KodamaJ, SekiN, NakamuraK, HongoA, HiramatsuY. Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.Oncol. Rep.23 (4), 917 – 925 (2010).
   PubMed Web of Science ®Google Scholar
• Ricciardelli C , SakkoAJ, WeenMP, RussellDL, HorsfallDJ. The biological role and regulation of versican levels in cancer.Cancer Metastasis Rev.28 (1–2), 233 – 245 (2009).
   PubMed Web of Science ®Google Scholar